Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Qiagen N.V.    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 1 418 1 502 1 530 1 559 1 664 1 778
EBITDA 476 514 552 568 615 637
Operating profit (EBIT) 372 403 422 432 469 509
Pre-Tax Profit (EBT) 114 226 -77,8 284 337 385
Net income 40,4 190 -41,5 226 267 316
P/E ratio 182x 42,0x -188x 38,1x 31,6x 26,8x
EPS ( $ ) 0,17 0,82 -0,18 1,04 1,26 1,49
Dividend per Share ( $ ) - - - - - -
Yield - - - - - -
Reference price ( $ ) 30,930 34,450 33,800 39,810 39,810 39,810
Announcement Date 01/31/2018
12:00am
02/04/2019
12:00am
02/04/2020
12:00am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt 741 781 953 925 686 380
Finance - - - - - -
Operating income (EBITDA) 476 514 552 568 615 637
Leverage
(Debt/EBITDA)
1,56x 1,52x 1,73x 1,63x 1,12x 0,60x
Capital Expenditure 90,1 110 118 130 135 144
Free Cash Flow (FCF) 197 250 213 303 361 401
Book Value Per Share (BVPS) ( $ ) 12,7 11,7 11,0 11,8 12,7 13,8
Cash Flow per Share ( $ ) 1,23 1,54 1,42 1,38 2,22 2,21
Announcement Date 01/31/2018
12:00am
02/04/2019
12:00am
02/04/2020
12:00am
- - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 9 062 M $ -
Entreprise Value (EV) 9 987 M $ 9 748 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 38,1x 31,6x
Capitalization / Revenue 5,81x 5,45x
EV / Revenue 6,41x 6,00x
EV / EBITDA 17,6x 16,2x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 3,37x 3,13x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 27,7% 28,2%
Operating Leverage (Delta EBIT / Delta Sales) 1,22x 1,30x
Net Margin (Net Profit / Revenue) 14,5% 16,0%
ROA (Net Profit / Asset) 5,12% 6,11%
ROE (Net Profit / Equities) 11,4% 12,0%
Rate of Dividend - -
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   8,33% 8,11%
Cash Flow / Sales 20,2% 30,4%
Capital Intensity (Assets / Sales) 2,83x 2,62x
Financial Leverage (Net Debt / EBITDA) 1,63x 1,12x
EPS & Dividend